Evidence map›Paper›PMID 31718545›Full record

ArticleBMC microbiology2019

A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria.

Meysam Sarshar, Daniela Scribano, Giulia Tranquilli, Marisa Di Pietro, Simone Filardo, Carlo Zagaglia, Rosa Sessa, Anna Teresa Palamara, Cecilia Ambrosi

Abstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meysam SarsharDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Laboratory affiliated to Institute Pasteur Italia-Fondazione Cenci Bolognetti, 00185, Rome, Italy.
Daniela ScribanoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Giulia TranquilliDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Marisa Di PietroDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Simone FilardoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Carlo ZagagliaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Rosa SessaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.
Anna Teresa PalamaraDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Laboratory affiliated to Institute Pasteur Italia-Fondazione Cenci Bolognetti, 00185, Rome, Italy.
Cecilia AmbrosiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy. cecilia.ambrosi@uniroma5.it.ORCID 0000-0003-2163-1613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuantification of intracellular bacteria is fundamental in many areas of cellular and clinical microbiology to study acute and chronic infections. Therefore, rapid, accurate and low-cost methods represent valuable tools in determining bacterial ability to persist and proliferate within eukaryotic cells.

resultsHerein, we present the first application of the immunofluorescence In-Cell Western (ICW) assay aimed at quantifying intracellular bacteria in in vitro infection models. The performance of this new approach was evaluated in cell culture infection models using three microorganisms with different lifestyles. Two facultative intracellular bacteria, the fast-growing Shigella flexneri and a persistent strain of Escherichia coli, as well as the obligate intracellular bacterium Chlamydia trachomatis were chosen as bacterial models. The ICW assay was performed in parallel with conventional quantification methods, i.e. colony forming units (CFUs) and inclusion forming units (IFUs). The fluorescence signal intensity values from the ICW assay were highly correlated to CFU/IFUs counting and showed coefficients of determination (R

conclusionsThe ICW assay offers several advantages including sensitivity, reproducibility, high speed, operator-independent data acquisition and overtime stability of fluorescence signals. All these features, together with the simplicity in performance, make this assay particularly suitable for high-throughput screening and diagnostic approaches.

Indexed as

Bacterial InfectionsBacteriological TechniquesCell LineChlamydia trachomatisColony Count, MicrobialEscherichia coliHeLa CellsHigh-Throughput Screening AssaysHumansModels, BiologicalReproducibility of ResultsShigella flexneriCFUHigh-throughputIFUImmunofluorescenceIn-cell WesternIntracellular bacterial quantification

Identifiers

PMID31718545
PMCPMC6849193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.